Week in Review: Strong First Quarter for IPOs, JOBS Act Becomes Law
The first quarter of 2012 has come and gone, leaving positive signs for venture capitalists. Twenty venture-backed start-ups made their IPO in the past three…
Posted by
The first quarter of 2012 has come and gone, leaving positive signs for venture capitalists. Twenty venture-backed start-ups made their IPO in the past three…
Posted by
The same technologies driving Enterprise 3.0 have also been revolutionizing health management. This convergence of technology and healthcare has built up momentum recently through new…
Posted by
Readers of this blog are well aware that entrepreneurship is one of our key themes—from our partner company CEO Q&A Series to our book recommendations…
Posted by
The past two weeks were brought to you by the letters IPO. From Facebook’s well-documented filing to this week’s IPO price cuts, a flurry of…
Posted by
Last year was a strong year for venture capital, according to the MoneyTree report issued by the National Venture Capital Association. Investments grew 22 percent…
Posted by
The convergence between life sciences and technology cannot be ignored. That’s why at Safeguard Scientifics, we consolidated of our life sciences and technology deal teams.…
Posted by
Ninety percent of migraine sufferers experience nausea, while 60 percent experience vomiting because of their migraine. As a result, today’s most common migraine treatments that…
Posted by
According to a report published by Cambridge Associates LLC, private equity and venture capital funds in the U.S. continued to generate positive returns for their…
Posted by
Earlier this week we held our Fifth Annual Investor Day 2011 where investors and analysts heard presentations from Safeguard executives and highlighted partner companies on…
Posted by